Eastman Chemical (NYSE: EMN) reported Q2 EPS of $1.68, $0.05 worse than the analyst estimate of $1.73. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.36 billion.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.